She Left Google to Build Tech That Could Save Millions w/ Mary Lou Jepsen | EP #142
The podcast episode introduces Mary Lou Jepsen, an entrepreneur and technologist, and discusses her innovative medical technology company, Open Water, which aims to revolutionize healthcare through exponential technologies and affordable devices. Mary Lou Jepsen discusses the importance of revolutionizing healthcare, her experience with a brain tumor, and her involvement in companies like micro display and Viome. The conversation covers the development of the $1,000 laptop project, its impact on the education technology industry, and future visions for screens and large-scale video walls. The podcast discusses the potential of Open Water's technology to revolutionize healthcare, reduce costs, and save millions of lives, highlighting the current inefficiencies in drug and device approval processes. The conversation focuses on using advanced medical technology to improve patient care, part
Discusses the future of screens and their potential to create immersive experiences like large-scale video walls that look identical to views out the window.
Mary Lou Jepsen discusses her company Fountain Life, which offers advanced diagnostic centers and therapeutic treatments to detect and prevent diseases early.
Mary Lou Jepsen reflects on her experience in large tech companies and the challenges of bringing new technologies to market, leading her to start her own company.
Mary Lou Jepsen discusses the progress and challenges in developing wearable AR/VR specs, noting the significant investment and lack of practical applications.
Predictions made
openUnknown: The technology will be democratized and affordable, making it accessible to everyone.
“viome has a product that I've personally used for years called full body intelligence which collects a few drops of your blood spit and stool and can tell you so much about your health”
Your call:
openUnknown: Screens will become more affordable and be used for large-scale video walls that look identical to views out the window.
“so the results are pretty spectacular uh and you developed this early on for strokes as well stroke detection”
Your call:
openMary Lou Jepsen: Regulatory approval will become like apps on an Android phone, making it easier for companies to get approval and make money on the technology.
“I can imagine everybody having one of these systems at home and they can find the app I want to be happier I want to get better sleep I mean there's going to be anything that your brain you know implements or or impacts um right and you can get through clinical trials easier because everybody can have this at home so you can try it more easily”
Your call:
Numbers that matter
10 yearsJepsen has been working on this technology for nearly 10 years, with significant results and plans to scale out.
80%The technology is clearing 80% of microclots, reducing their size from 8 Micron diameter to 4 Micron diameter.
5 to 10 micronsCapillaries are 5 to 10 microns wide, making the technology's ability to target microclots significant.
Multi-million dollarTraditional MRI or CT machines cost millions of dollars, while the new technology can achieve similar results with smartphone camera chips.
700,000Individuals tested by Viome
36%Reduction in depression after 6 months of following Viome's recommendations
40%Reduction in anxiety after 6 months of following Viome's recommendations
30%Reduction in diabetes after 6 months of following Viome's recommendations
MillionsProduced a large number of $1,000 laptops.
30,000people reached out for Fountain Life memberships after the New York Times bestseller
20centers being built around the world by Fountain Life
25%25% of the US economy goes towards healthcare expenses.
$3 billionCost of new drug approval with a cycle time of 26 years.
$700 millionCost of novel medical device approval over 13 years.
10,000 to 100,000 patientsNumber of patients required for clinical trials for a bigger disease like mental disease or neurodegenerative disease.